A: According to ro.co , eligibility requirements include: Age 18+ (some services may require 21+) Resident of state where Ro operates weight loss services BMI 30 (obesity) OR BMI 27 (overweight) with at least one weight-related condition No personal or family history of medullary thyroid carcinoma (MTC) No Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Not pregnant, planning pregnancy within 2 months, or breastfeeding No contraindications for GLP-1 medications Provider approval required based on comprehensive medical evaluation Meeting basic eligibility doesn't guarantee medication approval
In a clinical trial comparing tirzepatide and semaglutide, people taking tirzepatide showed roughly 20 percent drops in weight in a similar amount of time, while people on semaglutide lost around 14 percent
By modulating neurotransmitter levels, reducing neuroinflammation (40), and enhancing cognitive function through oxidative stress protection and increased hippocampal synaptic plasticity (36), it exerts protective effects against AD, as evidenced in preclinical studies
Besides, another effect that many patients report is improved skins elasticity after several of the treatments
Tissues were stained with mouse-specific antibodies GLP1R (abcam: ab218532) (A-H)
Because oral semaglutide has a bioavailability of roughly 0.4% to 1%